Fortive Corporation research snapshot
FTV AI stock analysis currently reads Fortive Corporation as a high-margin industrial technology and healthcare workflow company with credible Fortive Business System execution, roughly 50% recurring revenue, accelerating core growth, and strong free cash flow conversion. Q2 2026 delivered 7.9% reported and 6.7% core revenue growth, $0.74 adjusted EPS, and a raised FY2026 adjusted EPS guidance of $2.95 to $3.05. The main limits are a full valuation, modest organic growth relative to the multiple, debt built up through aggressive buybacks, Advanced Healthcare Solutions margin softness, and a 9.1% post-earnings selloff on July 29 that shows how high expectations had become. FTV closed at $59.21 on July 31, 2026, and the audited market cap check produced about $17.88 billion using 302.02 million shares outstanding. This FTV AI stock forecast is scenario-based, not a price promise, and should be used as an information tool rather than investment advice.
Current price
$59.21
Market cap
$17.88 billion verified market cap
AI score
69 / 100
Rating
Quality industrial technology compounder with accelerating core growth and strong cash conversion, at a full valuation after a post-earnings reset
Trend status
Fundamentals constructive but the short-term trend is neutral: price is above the 200-day moving average near $56.85 yet below the 50-day average near $60.88 after a 9.1% post-earnings drop
Data cutoff (updated monthly)
August 4, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Fortive sells mission-critical test and measurement instruments, sensors, safety systems, facility software, sterilization, biomedical testing, and clinical workflow tools. Gross margin is about 63%, roughly half of revenue is recurring, and Q2 2026 adjusted EBITDA margin was 29.5%. | Medium-high |
| Moat | Brand franchises such as Fluke, installed base, regulatory workflow friction, service channels, and software attachment create a narrow to moderate moat that is reinforced by the Fortive Business System. | Medium-high |
| Management | CEO Olumide Soroye is executing Fortive Accelerated: FBS Amplified growth, disciplined capital allocation, and investor trust. Q2 core growth accelerated to 6.7% and FY2026 guidance was raised, but the buyback pace needs to be weighed against rising debt. | Medium |
| Financial trend | Q2 2026 revenue rose 7.9% reported and 6.7% core, adjusted EPS rose 28.5% to $0.74, and TTM free cash flow reached $1,044 million. H1 2026 revenue was $2,166 million, up from $2,010 million in H1 2025. | High |
| Valuation | At $59.21, audited math shows 35.2x trailing EPS, 2.96x book value, 19.1x TTM free cash flow per share, 4.14x sales, and a 0.41% dividend yield. Forward adjusted P/E is about 20x on the raised guidance midpoint. | Medium-high |
| Technical trend | After a 9.1% post-earnings drop on July 29, price sits below the 50-day moving average near $60.88 and above the 200-day moving average near $56.85. RSI is about 43, so momentum is neutral to soft. | Medium |
| Risk level | Key risks are industrial demand cyclicality, hospital capital spending and reimbursement pressure, tariff and trade friction, a full valuation, higher debt from buybacks, and high expectations after a strong 2025 and first half of 2026. | Medium-high |
| AI confidence | Descriptive data confidence is high because the Q2 2026 filing and third-party market data are current. Forecast confidence is medium because forward EPS depends on growth durability, margin stability, tariffs, and capital allocation. | High data confidence |
| Investment certainty | FTV is a quality industrial technology name whose fundamentals improved in Q2 2026, but the market already trades it at a full multiple and the earnings-day drop showed how fragile sentiment is. Certainty is medium, not high. | Medium |
FTV AI stock forecast
The FTV AI stock forecast uses the $59.21 price reference, the raised FY2026 adjusted EPS guidance midpoint of $3.00, and a three-year earnings multiple model. The audited model produced a bearish value near $46, a base value near $70, and a bullish value near $96 before dividends. These are scenario ranges, not guaranteed targets.
$90 to $97
More likely if core growth stays near or above 6% to 7%, adjusted EBITDA margin expands toward 30%, free cash flow conversion remains strong, healthcare workflows recover, and the market keeps a multiple near 24x forward earnings.
$64 to $72
More likely if adjusted EPS compounds near 5%, Fortive keeps adjusted EBITDA margin near the 29% to 30% range, buybacks continue at disciplined prices, and the market applies about 20x forward earnings.
$44 to $50
More likely if industrial orders weaken, hospital capital spending slows, Advanced Healthcare Solutions margins keep falling, debt limits buyback capacity, or investors compress the multiple toward the mid-teens.
FTV AI technical analysis
FTV AI technical analysis uses market data available at the August 2, 2026 cutoff. FTV closed at $59.21 on July 31, 2026 after a 9.1% drop on July 29 when Q2 results were released. StockAnalysis showed RSI near 43.24, a 50-day moving average near $60.88, and a 200-day moving average near $56.85. Google Finance showed a 52-week high of $64.56 and a 52-week low of $46.34.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $59.21 | July 31, 2026 close from Google Finance and StockAnalysis market data. |
| Post-earnings low | $58.28 | The July 29 earnings-day low from MarketBeat is the first level that held the selloff. |
| Near-term support | $58.28 to $58.66 | The earnings-day low and the MarketBeat 200-day moving average estimate form the first support zone. |
| Key trend support | $56.85 | The StockAnalysis 200-day moving average is the main trend line that kept the decline contained. |
| Deeper support | $54.00 to $56.00 | A wider risk-control area below the 200-day average if industrial or healthcare demand deteriorates. |
| 50-day trend | $60.88 | Price sits below this level, so the short-to-intermediate trend is neutral after the earnings gap down. |
| 200-day trend | $56.85 | A hold above this level keeps the larger repair trend intact. |
| Resistance zone 1 | $61.01 to $61.50 | The 50-day moving average zone is the first hurdle on any rebound attempt. |
| Resistance zone 2 | $64.09 to $64.56 | The pre-earnings close on July 28 and the 52-week high are the main breakout zone. |
| Momentum | RSI near 43.24, MACD flattening | Momentum turned neutral to soft after the earnings gap down, so confirmation above the 50-day average matters. |
| Volume | About 4.24 million on July 29 versus 3.41 million average | The July 29 drop came on about 24% above-average volume, a sign of real distribution rather than noise. |
| Volatility | Earnings-sensitive and industrial-cycle sensitive | FTV can reprice quickly around earnings, orders, healthcare spending, tariffs, and capital allocation news. |
| Invalidation | Close below $56.85 | A decisive close below the 200-day moving average would reduce confidence in the current setup. |
FTV AI trading strategy
The FTV AI trading strategy below is a rules-based research framework, not personal advice. It connects price action with core revenue growth, adjusted EBITDA margin, free cash flow conversion, buyback discipline, healthcare demand, leverage, and post-spin execution.
Watch for FTV to reclaim the 50-day moving average near $60.88 on above-average volume and to build toward the $64.09 to $64.56 resistance zone, while Q3 commentary keeps the FY2026 adjusted EPS guidance range of $2.95 to $3.05 intact.
A close below the 200-day moving average near $56.85, a core growth slowdown below the mid-single digits, or weaker free cash flow conversion should reduce trend-following confidence.
If FTV pulls back toward $56.85 to $58.66 without deterioration in orders, margins, leverage, or healthcare demand, compare the entry price with the audited base and bear scenarios before acting.
Do not treat the stock as cheap only because it fell 9.1%. At about 20x forward adjusted EPS, valuation still requires durable execution and stable margins.
Track IOS and AHS sales, core revenue growth, adjusted EBITDA margin, free cash flow conversion, net debt, buyback price discipline, recurring revenue and software ARR, and commentary on Fortive Accelerated and AI-enabled workflows.
Position sizing should reflect that FTV is a quality cyclical industrial technology company, not a risk-free compounder or a bond substitute.
Investment research summary
Customers pay Fortive for reliable test and measurement instruments, safety systems, facility software, sterilization, biomedical testing, and clinical workflow support that improve uptime, compliance, productivity, and care delivery. Roughly half of revenue is recurring.
Fortive benefits from trusted brands such as Fluke, installed base, regulatory and workflow switching friction, service channels, software attachment, and the Fortive Business System. The moat narrows if competitors match reliability or customers defer replacements.
The thesis fails if core growth slows after the Ralliant separation, if buybacks happen at rich prices and inflate per-share metrics, if healthcare spending and AHS margins keep falling, if tariffs or trade friction raise costs, or if a quality or cybersecurity event damages trust.
CEO Olumide Soroye is executing Fortive Accelerated with three pillars: FBS Amplified growth, disciplined capital allocation, and investor trust. The Q2 core growth acceleration to 6.7% and the raised guidance are early evidence, but the buyback pace must be weighed against debt.
Fortive sits in durable trends around industrial automation, connected worker safety, facility software, healthcare productivity, sterilization, compliance, and AI-assisted workflows. These are attractive but cyclical trends tied to industrial and hospital budgets.
At $59.21, FTV is not priced as a deep value stock. The base-case margin of safety depends on adjusted EPS compounding near 5%, strong free cash flow conversion, and a market multiple near 20x forward earnings.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| FTV quote reference | $59.21 close on July 31, 2026 | Google Finance FTV quote page and StockAnalysis market data | August 2, 2026 |
| Market capitalization verification | $17.88 billion calculated from $59.21 x 302.02 million shares outstanding, cross-validated with Google Finance and MarketBeat | Pineify financial_rigor.py, StockAnalysis, and Google Finance | August 2, 2026 |
| Shares outstanding | 302.02 million common shares outstanding, down about 8.2% year over year | StockAnalysis statistics based on S&P Global data | August 2, 2026 |
| Q2 2026 results | $1,096.8 million revenue up 7.9% reported and 6.7% core, $157 million GAAP net earnings, $0.51 GAAP diluted EPS, $0.74 adjusted EPS up 28.5%, adjusted EBITDA margin 29.5%, $271 million free cash flow, TTM free cash flow $1,044 million | Fortive Q2 2026 results press release | August 2, 2026 |
| FY2026 guidance | Adjusted diluted EPS raised to $2.95 to $3.05 from the prior $2.90 to $3.00 range | Fortive Q2 2026 results press release | August 2, 2026 |
| FY2025 continuing operations | $4,159.1 million revenue up 1.9%, $533 million GAAP net income, adjusted EBITDA margin 29.6%, adjusted EPS $2.71, GAAP diluted EPS $1.59, free cash flow $931 million | Fortive Q4 and full year 2025 results press release | August 2, 2026 |
| Cash and debt | $374.2 million cash and equivalents, $3,509.3 million long-term debt, no current long-term debt, and 302.6 million shares outstanding as of July 3, 2026; StockAnalysis lists total debt near $3.6 billion | Fortive Q2 2026 Form 10-Q and StockAnalysis | August 2, 2026 |
| Valuation ratios | Audited math: 35.2x trailing EPS, 2.96x book value, 19.1x TTM free cash flow per share, 4.14x sales, 0.41% dividend yield, about 20x forward adjusted EPS on the guidance midpoint | Pineify financial_rigor.py using StockAnalysis and Google Finance inputs | August 2, 2026 |
| Daily technical indicators | RSI 43.24, 50-day moving average $60.88, 200-day moving average $56.85 (StockAnalysis); 50-day $61.01 and 200-day $58.66 (MarketBeat) | StockAnalysis FTV statistics and MarketBeat | August 2, 2026 |
| Market data, analyst view, and price action | 52-week high $64.56 and low $46.34, beta near 1.0, consensus Hold with average price targets from about $63 to $65, short interest 4.4% of shares, 9.1% drop on July 29 to $58.28 on above-average volume, $59.21 close on July 31 | Google Finance, StockAnalysis, and MarketBeat | August 2, 2026 |
This page is an informational research tool only and is not investment advice, a recommendation, or a promise of future performance. Forecast scenarios are based on available public data as of August 2, 2026, and may be wrong if Fortive growth, margins, capital allocation, debt, healthcare demand, industrial demand, tariffs, or market multiples change.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
